How long will it take for us to know the effectiveness of polylaminin? Understand the substance in 16 topics
Polylaminin has generated significant attention on social media due to its association with reports of patient recovery, but experts urge caution due to a lack of robust clinical evidence supporting its efficacy and safety.
Delegate who survived accident with police vehicle receives dose of polylaminin in an attempt to walk again
Delegate Leonardo Sanches, paralyzed after a car accident, has received polylaminin treatment, becoming the first individual in Goiás to access this potentially life-altering therapy.
Polylaminin: How the studies were conducted, what are the results so far, and what does Anvisa say? Understand
A groundbreaking Brazilian study on polylaminin shows promising results in restoring movement after severe injuries, with a pivotal clinical study approved by Anvisa set to begin next month.
'Self-promotion with little scientific methodology', says reader about medication for patients with spinal cord injury
A reader critiques the promotion of a medication for spinal cord injury patients, arguing it lacks sufficient scientific backing.
Neurologists alert to lack of evidence on the action of poly-L-lysine in spinal cord injury
Brazilian neurologists warn about insufficient scientific evidence supporting the use of poly-L-lysine for treating spinal cord injuries in humans.
Polylaminin: Maranhão native who received the substance begins home treatment and shows improvement
Hector Lucena, a 26-year-old agronomy student from Balsas, Maranhão, has begun at-home treatment with polylaminin for spinal cord trauma and reports improvements in his health.
VIDEO: Reporter Flávia Cintra hugs biologist Tatiana Sampaio, researcher leading studies on polylaminin
Reporter Flávia Cintra shares an emotional moment with biologist Tatiana Sampaio during a segment on the substance polylaminin, which offers hope for those with spinal cord injuries, going viral on social media.
This is Fantastic: the advances in experimental treatments with polylaminin
The article discusses promising advancements in experimental treatments involving polylaminin, a placenta-derived protein that may restore movement in patients with severe spinal cord injuries.
VIDEO: João Gomes interrupts show in Sapucaí to honor scientist leading research on polylaminin
Singer João Gomes interrupted a performance to pay tribute to researcher Tatiana Sampaio, who is recognized for her work on polylaminin for treating acute spinal cord injuries.
Scientific societies call for caution and precision in the debate over poly-laminin
Scientific societies in Brazil urge caution in the discussion surrounding poly-laminin, a protein under investigation for spinal cord injury regeneration, emphasizing the importance of distinguishing experimental research from established clinical application.
Polylaminin and Tatiana Sampaio go viral on social media, but fall well below Virginia, says survey
Biologist Tatiana Sampaio has gained 16 million interactions on social media, receiving significant attention for her research on polylaminin, a protein aimed at aiding spinal cord injury regeneration.
Patient walks again and polylaminin trends; understand what the substance can do and what is still unknown
Polylaminin has recently gained attention on social media due to a patient's recovery and ongoing discussions about its potential and patent issues in Brazil.
Claes Hultling: That's why we had a sex room at the Spinal Clinic
Claes Hultling, a 31-year-old anesthesiologist, reflects on his transformative experience as a patient after a life-changing injury and shares his innovative ideas for the treatment of spinal cord injuries.
Tatiana Sampaio, scientist who developed a molecule that can reverse spinal cord injuries, participates in event at IFTM in Patrocínio
Tatiana Sampaio, a leading researcher in spinal cord injury recovery, will participate in the 'Extraordinary Women' event at the IFTM in Patrocínio, Brazil.
"Dancing Therapy" Restores Spinal Cord Injury in the Laboratory
Researchers at Northwestern University created the most detailed spinal cord model to date in the lab, inducing injury and subsequently treating it with 'dancing molecules.'
Polylaminin: a molecule discovered in Brazil 'by chance' that became hope to reverse spinal cord injuries
Polylaminin, a modified version of the naturally occurring laminin protein, is being studied as a new potential treatment for spinal cord injury victims in Brazil, although it is still in early clinical trial phases.
Podcast: the Brazilian experimental drug that may be hope for spinal cord injuries
The podcast discusses polylaminin, an experimental drug showing promise in restoring movement for patients with spinal cord injuries, highlighted by the case of a Brazilian influencer who regained arm movement after treatment.